Overview
Hereditary hyperferritinemia-cataract syndrome (HHCS) is a rare genetic disorder characterized by elevated serum ferritin levels and early-onset bilateral cataracts. It is caused by mutations in the iron-responsive element (IRE) located in the 5' untranslated region of the FTL gene (ferritin light chain gene) on chromosome 19q13. These mutations disrupt the normal regulation of ferritin light chain production, leading to overproduction and accumulation of ferritin in the lens of the eye and elevated ferritin levels in the blood. Importantly, despite the high serum ferritin levels — which can range from 1,000 to over 2,000 µg/L — patients do not have iron overload, and iron studies such as transferrin saturation remain normal. The hallmark clinical features are persistently elevated serum ferritin and bilateral cataracts that typically develop in childhood or early adulthood, though they may be present from birth. The cataracts are caused by crystalline deposits of ferritin light chain (L-ferritin) within the lens and tend to be progressive, often described as having a distinctive 'breadcrumb' or 'sunflower' pattern on slit-lamp examination. Vision impairment varies from mild to significant, depending on the severity and location of the lens opacities. A major clinical concern is that patients are frequently misdiagnosed with hemochromatosis due to the elevated ferritin and may undergo unnecessary phlebotomy or liver biopsy, which can lead to iron deficiency anemia. There is no specific medical treatment to prevent or reverse the cataracts in HHCS. Management is primarily surgical, with cataract extraction performed when visual impairment becomes functionally significant. Cataracts may recur after surgery if lens material remains. Genetic counseling is important for affected families. Awareness of this condition among clinicians is essential to avoid inappropriate treatment for presumed iron overload. The prognosis is generally good, as the condition does not cause organ damage related to iron deposition.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Hereditary hyperferritinemia-cataract syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary hyperferritinemia-cataract syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hereditary hyperferritinemia-cataract syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary hyperferritinemia-cataract syndrome.
Community
No community posts yet. Be the first to share your experience with Hereditary hyperferritinemia-cataract syndrome.
Start the conversation →Latest news about Hereditary hyperferritinemia-cataract syndrome
No recent news articles for Hereditary hyperferritinemia-cataract syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary hyperferritinemia-cataract syndrome
What is Hereditary hyperferritinemia-cataract syndrome?
Hereditary hyperferritinemia-cataract syndrome (HHCS) is a rare genetic disorder characterized by elevated serum ferritin levels and early-onset bilateral cataracts. It is caused by mutations in the iron-responsive element (IRE) located in the 5' untranslated region of the FTL gene (ferritin light chain gene) on chromosome 19q13. These mutations disrupt the normal regulation of ferritin light chain production, leading to overproduction and accumulation of ferritin in the lens of the eye and elevated ferritin levels in the blood. Importantly, despite the high serum ferritin levels — which can r
How is Hereditary hyperferritinemia-cataract syndrome inherited?
Hereditary hyperferritinemia-cataract syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.